PKPD

A patient has experienced substantial weight gain over the past several months, which may lead to an increase in tissue binding of a lipophilic medication. Under conditions of distribution equilibrium, an increase in drug binding within tissues would be expected to result in a decrease in which of the following?

Concentration of bound drug in plasma

What is the usual clinical impact of decreased plasma protein binding?

Minimal effect on half-life

Rate of renal excretion =

Rate of secretion + (Rate of filtration – Rate of reabsorption)

Regarding the influence of urinary pH on the renal clearance of weakly acidic and weakly basic drugs, which of the following statements is generally correct, assuming that tubular reabsorption contributes to the drug’s renal excretion?

A decrease in urinary pH is expected to increase the renal clearance of a weak base with a pKa of 7, which is nonpolar in its unionized form.

Which of the following factors is most likely to influence the glomerular filtration of a drug?

The rate of renal blood flow

Which of the following types of drugs is most likely to exhibit a large volume of distribution?

small‑molecule, lipophilic drug

Under conditions of distribution equilibrium, an increase in the plasma protein binding of a drug leads to:

A decrease in the total drug concentration within tissues.

With respect to the Michaelis–Menten constant (Km), which of the following statements is ture?

Km reflects the binding affinity of an enzyme for its substrate or drug.

The metabolic clearance (CL_m) is defined as follows:

The ratio of the rate of metabolism of the parent drug to the plasma concentration of the parent compound (CLm = (dAm/dt)/C)

Under conditions of passive diffusion, which of the following factors exerts the greatest influence on the rate at which a drug penetrates biological membranes?

The lipophilicity of the drug

Regarding drug binding in plasma and tissues, which of the following statements is true?

Alterations in plasma protein binding produce larger changes in the volume of distribution for drugs that are highly protein‑bound than for those with low protein binding.

Regarding flip‑flop kinetics, which of the following statements is true?

The absorption process serves as the rate‑limiting step for drug elimination

Compared with the fasting state, the administration of a heavy meal is likely to:

Prolong the time required to reach the maximum plasma concentration (tmax) of a drug administered in an enteric‑coated tablet.

For an orally administered drug, if the volume of distribution decreases, how should the time required to reach the maximum plasma concentration (t_max) be expected to change?

decrease

Which of the following is considered the link between systemic absorption and elimination?

First‑pass events in the intestine and liver

Under conditions of distribution equilibrium, which of the following statements is true?

The ratio of protein‑bound drug concentration in plasma to that in tissues remains constant.

For a low–extraction ratio drug, in which total clearance is effectively equivalent to hepatic clearance, a reduction in plasma protein binding will lead to which of the following outcomes?

A decrease in the total drug concentration at steady state

For a high extraction‑ratio (high ER) drug that is primarily eliminated by hepatic mechanisms, which of the following statements is true?

Its elimination half‑life (t1/2) is directly related to the fraction unbound in plasma (fu).

For any given drug, the theoretical upper limits of the following pharmacokinetic parameters are:

The maximum renal clearance is equivalent to the renal plasma flow rate.

Biliary clearance is defined as the proportionality constant that relates the concentration of unchanged drug in:

Plasma to the rate of excretion of unchanged drug into the bile.

Regarding the determinants of the rate and extent of drug distribution, which of the following statements is correct?

The distribution half‑life of a drug within an organ or tissue is related to the volume of that organ or tissue.

Which of the following leads to a modification in the metabolic activity of an enzyme toward a drug?

The presence of a non‑competitive inhibitor

Gr>gf

Filtration and SECRETION

Gr<Gf

Filtration and REABSORPTION